SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shree Ganesh Remed. - Quaterly Results

05 Feb 2025 Evaluate
The revenue slipped marginally during the December 2024 quarter. A decline of about Rs. 270.53 millions was observed as compared to Rs. 279.74 millions during the corresponding quarter last year.The Company has registered profit of Rs. 54.33  millions for the quarter ended December 2024, a growth of 13.19%  over Rs. 48.00 millions millions achieved in the corresponding quarter of last year.Operating Profit saw a handsome growth to 106.10 millions from 93.19 millions in the quarter ended December 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 270.53 279.74 -3.29 841.65 882.24 -4.60 1258.95 913.58 37.80
Other Income 7.10 11.12 -36.15 14.43 22.37 -35.49 30.67 7.17 327.75
PBIDT 106.10 93.19 13.85 307.77 265.81 15.79 448.77 241.60 85.75
Interest 3.75 0.18 1983.33 11.19 0.64 1648.44 5.98 1.80 232.22
PBDT 102.35 93.01 10.04 296.58 265.17 11.85 442.79 239.80 84.65
Depreciation 27.00 18.81 43.54 71.42 43.01 66.05 61.10 37.42 63.28
PBT 75.35 74.20 1.55 225.16 222.16 1.35 381.69 202.38 88.60
TAX 21.02 26.20 -19.77 60.15 63.21 -4.84 100.52 50.53 98.93
Deferred Tax 0.22 6.00 -96.33 0.36 6.89 -94.78 6.74 -2.84 -337.32
PAT 54.33 48.00 13.19 165.01 158.95 3.81 281.17 151.85 85.16
Equity 128.43 125.11 2.65 128.43 125.69 2.18 125.83 121.07 3.93
PBIDTM(%) 39.22 33.31 17.73 36.57 30.13 21.37 35.65 26.45 34.79

Shree Ganesh Remed. Share Price

533.90 26.70 (5.26%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×